People who have diabetes can develop diabetic eye disease such as Clinically Significant Macular Edema (CSME), which is progressive and if left untreated, can cause visual impairment and loss of fine detailed vision. Detecting the disease early through regular eye tests can help prevent vision deterioration.
If you suffer from diabetes, the high blood sugar levels can damage blood vessels in the retina, an important nerve layer at the back of the eye that senses light and helps to send images to the brain. This damage to blood vessels is known as Diabetic Retinopathy (DR). Clinically Significant Macular Edema (CSME) is a form of Diabetic Retinopathy and results in swelling of the central retina (macular edema). CSME can cause visual impairment and blindness if left untreated.
It is important to remember that managing CSME is a lifelong process: even with 2RT™ Retinal Rejuvenation you will need to continue to visit your ophthalmologist every six months to monitor and manage diabetic eye conditions.
We are thrilled to announce that 2RT® Retinal Rejuvenation Therapy now forms part of Nova Eye Medical Limited.
From our base in Fremont, California, our team is working hard to develop 2RT® as a potential breakthrough therapy for patients with intermediate age-related macular degeneration (iAMD).